Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 12OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 3Gastrointestinal 3

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40Leukemia, Myeloid, Chronic-Phase 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia 5Blast Crisis 5Neoplasm Metastasis 3Melanoma 3Leukemia, Myeloid, Acute 3Gastrointestinal Stromal Tumors 3Synovitis, Pigmented Villonodular 2Recurrence 2Leukemia, Myeloid, Accelerated Phase 2Substance Withdrawal Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neurofibroma 1Neoplasms 1Neoplasm, Residual 1Mucosal Lentiginous Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Glioma 1Giant Cell Tumor of Tendon Sheath 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1

Interventions

Imatinib Mesylate 32regorafenib 9Sunitinib 9Laparoscopy 5Dasatinib 4Blood Specimen Collection 4pazopanib 3nilotinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Observation 3spartalizumab 2ripretinib 2envafolimab 2binimetinib 2apatinib 2Temozolomide 2Neoadjuvant Therapy 2Ipilimumab 2Gemcitabine 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2CTLA-4 Antigen 2Biopsy, Fine-Needle 2Biopsy 25-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Stromal Tumors × nilotinib × Clear all
NCT00976612 2020-01-07

Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Asan Medical Center

Completed
17 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00782834 2013-04-22

07060

Fox Chase Cancer Center

Phase 2 Terminated
13 enrolled 8 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01270893 2012-08-02

Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡